By
Oscar Gonzalez2025-07-07T17:15:00
U.S. Securities and Exchange Commission (SEC) Chair Paul Atkins sat down with CNBC last week to talk about the regulatory landscape for the commission. One topic he focused on was the newest investing trend of firms selling tokens of shares of private companies such as SpaceX and OpenAI, and how that will change regulations at the SEC.
”Tokenization and other aspects of doing the tokenization in the marketplace is yet the next step to have much more efficiency in the marketplace and, and certainty of having a trade settle,” Atkins said. ”We at the SEC should be focused on how do we advance innovation in the marketplace. And so, I would argue here, over the last several years, the SEC has been standing athwart efforts to innovate in the marketplace because things have been unclear. The rules have not been clear.”
2025-10-30T19:44:00Z By Ruth Prickett
The U.K. Financial Conduct Authority (FCA) has opened a consultation on its plans to support “tokenization” – the digital representation of assets on distributed ledger technology (DLT). It is calling for firms to respond to the consultation before November 21. The financial regulator said in a press release on Oct. ...
2025-09-15T20:00:00Z By Aly McDevitt
President Donald Trump is pushing for a shake-up in corporate reporting rules, calling on companies to file earnings with the SEC only twice a year instead of every quarter.
2025-08-13T18:00:00Z By Aly McDevitt
Securities and Exchange Commission Chairman Paul Atkins has launched “Project Crypto,” a major regulatory overhaul aimed at shifting the agency from enforcement to innovation. Atkins’ address outlined as many as nine Commission-wide initiatives to revamp the SEC’s rulebook for the digital finance era.
2025-12-05T19:25:00Z By Oscar Gonzalez
The U.S. Securities and Exchange Commission’s (SEC) Division of Examinations released its 2026 examination priorities, which give companies a roadmap of areas of heightened risk and regulatory focus for next year.
2025-12-04T22:15:00Z By Ruth Prickett
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.
2025-12-04T20:14:00Z By Oscar Gonzalez
Wholesale retailer Costco would like a tariff refund from the U.S. government, if the U.S. Supreme Court rules that President Donald Trump overstepped his authority by imposing them.
Site powered by Webvision Cloud